Senti Biosciences Income Statement (2021-2025) | SNTI

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.78M0.93M0.32M1.10M1.11M1.52M0.06M1.29M0.69M0.34M
Operating items
Research & Development (Quarter) 5.24M5.41M6.41M7.60M9.25M6.52M7.04M7.06M6.88M9.09M9.12M8.78M9.15M8.65M7.77M9.28M10.03M10.52M7.76M
Wages, Salaries and Other (Quarter) 3.70M1.28M
Selling, General & Administrative (Quarter) 4.55M7.12M5.27M5.26M13.88M9.99M9.82M9.19M9.25M9.43M9.30M7.52M4.21M6.56M8.08M7.12M6.77M6.43M5.85M
Other Operating Expenses (Quarter) 0.00M25.69M0.27M0.31M5.05M
Operating Expenses (Quarter) 0.00M9.79M12.53M11.68M12.86M23.13M16.51M16.85M16.25M16.12M44.21M18.70M16.30M13.36M15.21M16.17M16.40M16.80M16.95M18.66M
Operating Income (Quarter) -0.00M-9.00M-11.42M-3.87M-11.76M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.21M-16.17M-16.40M-16.80M-16.95M-18.64M
EBIT (Quarter) -0.00M-9.00M-11.42M-3.87M-11.76M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.21M-16.17M-16.40M-16.80M-16.95M-18.64M
Non-operating items
Interest & Investment Income (Quarter) 0.00M0.01M0.01M0.00M0.03M0.54M1.13M1.06M0.79M0.58M0.43M0.33M0.24M0.15M0.23M0.39M0.27M0.17M0.10M
Other Non Operating Income (Quarter) -0.10M-0.12M-0.05M1.34M1.32M-0.01M-0.00M-0.01M-0.01M0.01M-0.01M0.21M0.18M0.20M0.22M0.20M
Non Operating Income (Quarter) -3.01M0.02M14.73M-0.05M0.03M0.00M-0.00M1.11M0.94M7.26M0.01M0.01M-13.65M8.26M0.20M2.06M-1.18M4.17M
Net income details
EBT (Quarter) -0.00M-8.99M-11.42M-3.86M-11.75M-21.74M-14.21M-15.67M-13.90M-14.39M-43.29M-18.27M-15.97M-13.12M-15.06M-15.94M-16.00M-16.53M-16.78M-18.54M
Profit After Tax (Quarter) -0.00M-12.01M-11.41M-3.86M-11.81M-11.55M-16.64M-58.21M-18.72M-18.70M-14.92M-83.41M-12.11M-11.20M-28.87M-0.59M-14.11M-14.73M-18.13M-14.40M
Income from Continuing Operations (Quarter) -0.00M-8.99M-11.42M-3.86M-11.75M-21.74M-14.21M-15.67M-13.90M-14.39M-43.29M-18.27M-15.97M-13.12M-15.06M-15.94M-16.00M-16.53M-16.78M-18.54M
Consolidated Net Income (Quarter) -0.00M-8.99M-11.42M-3.86M-11.75M-21.74M-2.34M-8.54M-4.87M-4.45M21.69M-0.03M-16.00M-16.53M-16.78M-18.54M
Income towards Parent Company (Quarter) -0.00M-8.99M-11.42M-3.86M-11.75M-21.74M-2.34M-8.54M-4.87M-4.45M21.69M-0.03M-16.00M-16.53M-16.78M-18.54M
Net Income towards Common Stockholders (Quarter) -0.00M-8.99M-11.42M-3.86M-11.75M-21.74M-2.34M-8.54M-4.87M-4.45M21.69M-0.03M-12.11M-11.20M-28.87M-14.11M-14.73M-18.13M-18.54M
Additional items
EPS (Basic) (Quarter) 0.00-4.13-3.90-1.32-3.72-0.86-0.380.09-0.31-4.22-8.24-1.39-2.65-2.45-6.31-0.62-1.41-0.56-0.69-0.48
EPS (Weighted Average and Diluted) (Quarter) -4.13-3.90-3.67-3.72-0.86-0.33-0.24-0.42-4.22-8.24-4.18-2.65-2.45-6.31-0.62-1.41-0.56-0.69-0.48
Shares Outstanding (Weighted Average) (Quarter) 5.00M2.88M2.93M2.91M3.17M8.34M20.15M26.11M44.07M4.42M4.43M4.44M4.57M4.57M4.58M4.60M10.01M26.08M26.23M22.48M
Shares Outstanding (Diluted Average) (Quarter) 2.91M2.90M2.91M3.17M13.45M43.42M26.11M44.07M4.43M4.43M4.44M4.57M4.57M4.58M4.60M10.01M26.08M20.83M22.48M
EBITDA (Quarter) -0.00M-12.01M-11.41M-10.90M-11.81M-11.55M-16.64M-18.21M-18.72M-18.70M-14.92M-18.72M-12.11M-11.20M-28.87M-0.61M-14.11M-14.73M-18.13M-14.47M
Shares Outstanding (Quarter) 2.89M2.92M2.94M2.97M3.29M43.37M43.64M4.41M4.41M4.45M4.45M4.57M4.57M4.57M4.59M4.83M26.00M26.16M26.29M30.88M